Xcout Intel
Genascence
Genascence is a clinical-stage biotechnology company headquartered in Palo Alto, California. Backed by venture capital, the firm develops life-changing gene therapy products aimed at treating major prevalent musculoskeletal diseases beyond rare disorders.
Subscribe to see Genascence’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Genascence at a glance
Genascence is a gene therapy company headquartered in United States. Xcout tracks 9 named people at Genascence, including Thomas W. Chalberg (Founder, Chairman & CEO).
Genascence leadership
- Thomas W. ChalbergFounder, Chairman & CEO
- Annahita KeravalaFounder, Chief Scientific Officer
- Christopher H. EvansFounder
- Paul RobbinsFounder
- Steven C. GhivizzaniFounder
- Brian L. KotzinSenior Vice President and Chief Medical Officer at Nektar Therapeutics
3 more named people on record for Genascence, with roles, board committees and tenure — see the full roster →
Genascence competitors
A few of Genascence's closest competitors — see the full list of competitors and alternatives →
NellOne Therapeutics develops regenerative-medicine therapies based on NELL-1, a protein associated with bone formation and regeneration. Its work is aimed at treating bone defects and related orthopedic conditions for patients and healthcare providers.
Sarcomatrix Therapeutics Corp. is a biopharmaceutical and biotechnology research company headquartered in Reno, Nevada. The company is dedicated to pioneering muscle regeneration therapies and advancing novel therapeutics to treat muscle-wasting diseases.
OsteoCure Therapeutics is a biotechnology research company and Duke University spinout headquartered in Durham, North Carolina, developing first-in-class adenosine-based biologics to restore skeletal health.
Mendra is a venture-backed biotechnology research startup established in 2025 and headquartered in San Francisco, focused on accelerating the development and commercialization of rare disease therapies.
Scout Bio, Inc. is a veterinary biotechnology company specializing in animal health and advanced gene therapy treatments currently being evaluated in clinical trials.
LUCA Science is a pre-clinical stage biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs. The company utilizes a proprietary method to isolate functional mitochondria, combining it with advanced drug delivery and formulation technology to create storable biopharmaceutical agents.
Get Genascence's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Genascence in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access